Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Apr 03, 2009 12:19pm
344 Views
Post# 15894415

RE: Re: Q1 numbers

RE: Re: Q1 numbers

Sah... couldnt agree more..  And dont get me wrong... I am not sugar coating the lack of cash situation.  I am  just saying he has very viable options given the significant improvement in the underlying fundamentals.  Frankly as a reasonably large shareholder,  I would like to avoid further dilution at these levels.

Ironically... I have been in almost exactly PL's position with 60 employees.. and virtually nothing in the bank.  However,  we had good supplier credit,  and we had bankable recievables and contracts.   I really dont think we should underestimate the opportunities to fund in that manner...   

Think about this,  the projected revenues for this coming year of $25mm or so ( excluding any 1402 or PRDT ) is almost 65% of the MARKET CAP of this company right now ...if even ONE of the other things come thru... and I am obviously betting that they finally will....  we could potentially have a situation where our revenues are MORE than the current market cap.   

With good reason, the market isnt giving this company ANY benefit of the doubt or credibility in their projections.   HOWEVER,   If one of these catalysts come...  or EVEN if all we see this year is a 150% increase in recurring diversified revenue...   this imbalance will be rectified by a substantially higher share price.

If I am reading the market action correctly,  there is still a few blocks left for sale here.. but it looks like the overhang is clearing.  I think if we crack 14-15 here... we will be back in the low 20's and that itself will cause short covering and bring in more buyers.

SORRY STOCKPUT... I dont have that many bullets left !   We need a "team" approach here...
Bullboard Posts